Back

Dapagliflozin reduces the risk of hyperkalaemia in patients with heart failure and reduced ejection fraction: a secondary analysis DAPA-HF

29 August 2020 (08:30 - 08:30)
Organised by:
Congress Presentation Part of: Mechanisms of Heart Failure and Implications for Clinical Translation Heart Failure with Reduced Ejection Fraction (HFrEF) ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Soeren Lund Kristensen

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

7 More presentations in this session

Presentation thumbnail
Diagnostic usefulness of passive leg raising test for detection of heart failure with preserved ejection fraction compared to cycle ergometer exercise(invasive hemodynamic study)
Associate Professor S. Hwang (Incheon, KR)
Abstract Slides Video
Presentation thumbnail
Impact of catheter ablation on HFpEF in people with comorbid atrial fibrillation and HFpEF using invasive haemodynamic testing.
Doctor H. Sugumar (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
Characterization of myocardial sodium-glucose cotransporter 1 expression in humans with heart failure and reduced ejection fraction
Doctor A. Sayour (Budapest, HU)
Abstract Slides Video
Presentation thumbnail
Effect of sacubitril/valsartan on cognitive function in patients with HFpEF: A prespecified analysis of PARAGON-HF
Doctor P. Dewan (London, GB)
Abstract Slides Video
Presentation thumbnail
Sex-specific effect of obesity on exercise capacity and diastolic function
Doctor M. Jung (Seoul, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Mechanisms of Heart Failure and Implications for Clinical Translation

The Event

Event poster

ESC Congress 2020

29 August 2020 08:30 CET
You may be interested in
thumbnail
Webinar
Advanced heart failure therapy in HF patients with preserved and mildly reduced ejection fraction
thumbnail
Congress Session
Meet the Experts: summation of the science - treatment of chronic heart failure in 2023
thumbnail
Congress Session
Transforming heart failure care: unlocking new pathways

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources